Klinische Studie
Clinical Evidence of Skin Improvements With a Biologically Active Multimodal Topical Skin Treatment
Journal of Drugs in Dermatology · 2026
DOI: 10.36849/jdd.10086 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Drugs in Dermatology, 2026. Verfasst von Zein E Obagi und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Skin Aging, Dermatologic Agents, Peptides.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Skin AgingDermatologic AgentsPeptidesHumansFemaleMiddle AgedAdministration, CutaneousTreatment OutcomeAgedSkinFaceMicroscopy, Confocal
Substanzen
Dermatologic AgentsPeptides
Zitieren
APA
Obagi, Z. E., Balian, R. J., Ramsey, S. V., Woodin, F. W., & Nguyen, G. H. (2026). Clinical Evidence of Skin Improvements With a Biologically Active Multimodal Topical Skin Treatment. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.10086
Vancouver
Obagi ZE, Balian RJ, Ramsey SV, Woodin FW, Nguyen GH. Clinical Evidence of Skin Improvements With a Biologically Active Multimodal Topical Skin Treatment. Journal of Drugs in Dermatology. 2026. doi:10.36849/jdd.10086
BibTeX
@article{Obagi2026,
author = {Obagi, Zein E and Balian, Raffi J and Ramsey, Susan V and Woodin, Frederick W and Nguyen, Grace H},
title = {Clinical Evidence of Skin Improvements With a Biologically Active Multimodal Topical Skin Treatment},
journal = {Journal of Drugs in Dermatology},
year = {2026},
doi = {10.36849/jdd.10086}
}
EUVIMED